328 related articles for article (PubMed ID: 33724342)
1. Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition.
Bhargava P; Kim S; Reyes AA; Grenningloh R; Boschert U; Absinta M; Pardo C; Van Zijl P; Zhang J; Calabresi PA
Brain; 2021 Jun; 144(5):1396-1408. PubMed ID: 33724342
[TBL] [Abstract][Full Text] [Related]
2. BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions.
Gupta K; Kesharwani A; Rua S; Singh SS; Siu C; Jank L; Smith MD; Calabresi PA; Bhargava P
J Neuroinflammation; 2023 Oct; 20(1):229. PubMed ID: 37805549
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bruton's tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease.
Torke S; Pretzsch R; Häusler D; Haselmayer P; Grenningloh R; Boschert U; Brück W; Weber MS
Acta Neuropathol; 2020 Oct; 140(4):535-548. PubMed ID: 32761407
[TBL] [Abstract][Full Text] [Related]
4. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
[TBL] [Abstract][Full Text] [Related]
5. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair.
Geladaris A; Torke S; Saberi D; Alankus YB; Streit F; Zechel S; Stadelmann-Nessler C; Fischer A; Boschert U; Häusler D; Weber MS
Acta Neuropathol; 2024 Apr; 147(1):75. PubMed ID: 38656399
[TBL] [Abstract][Full Text] [Related]
6. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal resolution of spinal meningeal and parenchymal inflammation during experimental autoimmune encephalomyelitis.
Shrestha B; Jiang X; Ge S; Paul D; Chianchiano P; Pachter JS
Neurobiol Dis; 2017 Dec; 108():159-172. PubMed ID: 28844788
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
Haselmayer P; Camps M; Liu-Bujalski L; Nguyen N; Morandi F; Head J; O'Mahony A; Zimmerli SC; Bruns L; Bender AT; Schroeder P; Grenningloh R
J Immunol; 2019 May; 202(10):2888-2906. PubMed ID: 30988116
[TBL] [Abstract][Full Text] [Related]
9. Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis.
Kramann N; Neid K; Menken L; Schlumbohm C; Stadelmann C; Fuchs E; Brück W; Wegner C
Brain Pathol; 2015 May; 25(3):276-86. PubMed ID: 25041171
[TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination.
Evonuk KS; Wang S; Mattie J; Cracchiolo CJ; Mager R; Ferenčić Ž; Sprague E; Carrier B; Schofield K; Martinez E; Stewart Z; Petrosino T; Johnson GA; Yusuf I; Plaisted W; Naiman Z; Delp T; Carter L; Marušić S
Acta Neuropathol Commun; 2023 Jul; 11(1):115. PubMed ID: 37438842
[TBL] [Abstract][Full Text] [Related]
11. Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity.
Mitsdoerffer M; Di Liberto G; Dötsch S; Sie C; Wagner I; Pfaller M; Kreutzfeldt M; Fräßle S; Aly L; Knier B; Busch DH; Merkler D; Korn T
Brain; 2021 Jul; 144(6):1697-1710. PubMed ID: 33693558
[TBL] [Abstract][Full Text] [Related]
12. Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Montalban X; Arnold DL; Weber MS; Staikov I; Piasecka-Stryczynska K; Willmer J; Martin EC; Dangond F; Syed S; Wolinsky JS;
N Engl J Med; 2019 Jun; 380(25):2406-2417. PubMed ID: 31075187
[TBL] [Abstract][Full Text] [Related]
13. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.
Howell OW; Reeves CA; Nicholas R; Carassiti D; Radotra B; Gentleman SM; Serafini B; Aloisi F; Roncaroli F; Magliozzi R; Reynolds R
Brain; 2011 Sep; 134(Pt 9):2755-71. PubMed ID: 21840891
[TBL] [Abstract][Full Text] [Related]
14. Contribution of B cells to cortical damage in multiple sclerosis.
Bhargava P; Hartung HP; Calabresi PA
Brain; 2022 Oct; 145(10):3363-3373. PubMed ID: 35775595
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.
Magliozzi R; Columba-Cabezas S; Serafini B; Aloisi F
J Neuroimmunol; 2004 Mar; 148(1-2):11-23. PubMed ID: 14975582
[TBL] [Abstract][Full Text] [Related]
16. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
[TBL] [Abstract][Full Text] [Related]
17. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Wang X; Cusick MF; Wang Y; Sun P; Libbey JE; Trinkaus K; Fujinami RS; Song SK
NMR Biomed; 2014 Jul; 27(7):843-52. PubMed ID: 24816651
[TBL] [Abstract][Full Text] [Related]
18. Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
Church ME; Ceja G; McGeehan M; Miller MC; Farias P; Sánchez MD; Swain GP; Assenmacher CA; Stopa EG; Vite CH; Bar-Or A; Alvarez JI
J Immunol; 2021 Jul; 207(1):44-54. PubMed ID: 34162727
[TBL] [Abstract][Full Text] [Related]
19. Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers.
Becker A; Martin EC; Mitchell DY; Grenningloh R; Bender AT; Laurent J; Mackenzie H; Johne A
Clin Transl Sci; 2020 Mar; 13(2):325-336. PubMed ID: 31654487
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis.
Torke S; Weber MS
Expert Opin Investig Drugs; 2020 Oct; 29(10):1143-1150. PubMed ID: 32772592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
